Health Care: Drugs

Catalyst Pharmaceutical Partners Inc (CPRX: NASDAQ)

$2.27 -0.03 | -1.3%
08/21/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 2.27
52 Week High 3.65
52 Week Low 1.29
Avg. Daily Vol. (Mil) 0.49
Beta (3 year) 0.49
Share Related Items
Mkt Cap (Mil) 152.47
Shares Out (Mil) 67.17
Float (Mil) 41.73
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 19.00
Current Ratio 19.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 3.70
Price/Cash Flow -10.70
Per Share Data
Earnings -0.26
Sales 0.00
Book Value 0.61
Cash Flow -0.21
Business Summary
Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical Company. It develops and commercializes prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy.
General Information
355 Alhambra Circle
Suite 1500
Coral Gables, FL 33134
www.catalystpharma.com
Industry : Drugs
Sector: Health Care
Employees: 7
CEO: Patrick J. McEnany
Short Interest
Current Month (Mil) 5.50
Previous Month (Mil) 5.61
Short Interest Ratio (Days) 15.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -31.10
Return on Investments -34.70
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with CPRX

Latest CPRX Headlines from TheStreet

More Financial News for CPRX

Press Releases for CPRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter